The road to restore vision with photoreceptor regeneration

CJ Zhang, Y Ma, ZB Jin - Experimental Eye Research, 2021 - Elsevier
Neuroretinal diseases are the predominant cause of irreversible blindness worldwide,
mainly due to photoreceptor loss. Currently, there are no radical treatments to fully reverse …

Stem cell therapy in heart diseases: a review of selected new perspectives, practical considerations and clinical applications

E Abdelwahid, T Siminiak… - Current cardiology …, 2011 - ingentaconnect.com
Degeneration of cardiac tissues is considered a major cause of mortality in the western
world and is expected to be a greater problem in the forthcoming decades. Cardiac damage …

Combined transplantation of human mesenchymal stem cells and human retinal progenitor cells into the subretinal space of RCS rats

L Qu, L Gao, H Xu, P Duan, Y Zeng, Y Liu, ZQ Yin - Scientific reports, 2017 - nature.com
Retinitis pigmentosa (RP) is one of hereditary retinal diseases characterized by the loss of
photoreceptors. Cell transplantation has been clinically applied to treat RP patients. Human …

Simultaneous autologous transplantation of cocultured mesenchymal stem cells and skeletal myoblasts improves ventricular function in a murine model of Chagas …

LC Guarita-Souza, KAT Carvalho, V Woitowicz… - Circulation, 2006 - Am Heart Assoc
Background—Cellular transplantation is emerging as a promising strategy for the treatment
of postinfarction ventricular dysfunction. Whether its beneficial effects can be extended to …

[HTML][HTML] Combined transplantation with human mesenchymal stem cells improves retinal rescue effect of human fetal RPE cells in retinal degeneration mouse model

T Pan, H Shen, S Yuan, G Lu, Y Zhang… - … & Visual Science, 2020 - tvst.arvojournals.org
Purpose: We verified whether fetal RPE (fRPE) cells and mesenchymal stem cells (MSCs)
cotransplantation can combine the features of these two cell types and alleviate retinal …

Bone-Marrow Stem Cells and Acellular Human Amniotic Membrane in a Rat Model of Heart Failure

GG Blume, PAB Machado-Junior, RB Simeoni… - Life, 2021 - mdpi.com
Myocardial infarction (MI) remains the leading cause of cardiovascular death worldwide and
a major cause of heart failure. Recent studies have suggested that cell-based therapies with …

Enhanced cell therapy for ischemic heart disease

N Bonaros, R Rauf, T Schachner, G Laufer… - …, 2008 - journals.lww.com
Stem cell therapy is regarded as an innovative strategy to intervene in degenerative heart
disease. The efficacy of stem cell therapy to regenerate ischemic myocardium has been …

Cell transplantation: differential effects of myoblasts and mesenchymal stem cells

LC Guarita-Souza, KAT Carvalho, C Rebelatto… - International journal of …, 2006 - Elsevier
BACKGROUND: Cellular transplantation has emerged as a novel therapeutic option for
treatment of ventricular dysfunction. Both skeletal myoblasts (SM) and mesenchymal stem …

[PDF][PDF] Stem cell therapy for myocardial infarction: challenges and prospects

G Satessa, J Lenjisa, E Gebremariam… - J Stem Cell Res Ther, 2015 - academia.edu
Stem Cell Page 1 Volume 5 • Issue 3 • 1000270 J Stem Cell Res Ther ISSN: 2157-7633 JSCRT,
an open access journal Open Access Review Article Stem Cell Research & Therapy Satessa …

Analyzing impetus of regenerative cellular therapeutics in myocardial infarction

ML Chang, YJ Chiu, JS Li, KP Cheah… - Journal of Clinical …, 2020 - mdpi.com
Both vasculature and myocardium in the heart are excessively damaged following
myocardial infarction (MI), hence therapeutic strategies for treating MI hearts should …